Twist Bioscience Stock Surges 17% on AI Protein Testing Partnership with Anthropic

Key Facts

In a move highlighting the growing intersection of artificial intelligence and biotechnology, Twist Bioscience stock experienced a significant price surge. The company's shares jumped 17% to reach a new 52-week high according to reports. This momentum follows the announcement that AI startup Anthropic has selected Twist Bioscience to conduct testing on proteins designed by artificial intelligence.

The partnership positions Twist Bioscience as a critical infrastructure provider for AI-driven biological research. Per market dynamics, this rally reflects strong investor confidence in the firm's ability to support next-generation scientific discovery. This high-profile collaboration has intensified focus on the protein-design sector, pushing the stock beyond its previous annual price boundaries.

Looking ahead, price action for Twist Bioscience (TWST) remains a key focus for traders following its record levels, though specific real-time price data is currently unavailable. On the macro front, market participants are monitoring upcoming US Producer Price Index (PPI) data, which could influence broader sentiment across the technology and growth sectors.